This Article Full Text Full Text (PDF) All Versions of this Article: 99/10/1067    most recent 01.RES.0000250430.62775.99v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Esplugues, J. V. Articles by Victor, V. M. Search for Related Content PubMed PubMed Citation Articles by Esplugues, J. V. Articles by Victor, V. M. Related Collections Oxidant stress Endothelium/vascular type/nitric oxide Other Vascular biology

(Circulation Research. 2006;99:1067.)
© 2006 American Heart Association, Inc.

Molecular Medicine

Complex I Dysfunction and Tolerance to Nitroglycerin

An Approach Based on Mitochondrial-Targeted Antioxidants

Juan V. Esplugues, Milagros Rocha, Cristina Nuñez, Irene Bosca, Sales Ibiza, Jose R. Herance, Angel Ortega, Juan M. Serrador, Pilar D’Ocon, Victor M. Victor

From the Departamento de Farmacologia (J.V.E., M.R., P.D.), Facultad de Medicina, Universitat de Valencia; Unidad Mixta Centro Nacional de Investigaciones Cardiovasculares (CNIC)-Universitat de Valencia (C.N., I.B., S.I., J.M.S., V.M.V.); Instituto de Alta Tecnologia (J.R.H.), Parque de Investigaciones Biomedicas, Barcelona; and Unidad Central de Investigacion (A.O.), Universitat de Valencia, Spain.

Correspondence to Dr Victor M. Victor, Unidad Mixta CNIC-Valencia, Departamento de Farmacologia, Avda Blasco Ibañez 15-17, Valencia, Va 46010, Spain. E-mail vmvictor{at}cnic.es

Nitroglycerin (GTN) tolerance was induced in vivo (rats) and in vitro (rat and human vessels). Electrochemical detection revealed that the incubation dose of GTN (5x10^–6 mol/L) did not release NO or modify O₂ consumption when administered acutely. However, development of tolerance produced a decrease in both mitochondrial O₂ consumption and the K_m for O₂ in animal and human vessels and endothelial cells in a noncompetitive action. GTN tolerance has been associated with impairment of GTN biotransformation through inhibition of aldehyde dehydrogenase (ALDH)-2, and with uncoupling of mitochondrial respiration. Feeding rats with mitochondrial-targeted antioxidants (mitoquinone [MQ]) and in vitro coincubation with MQ (10^–6 mol/L) or glutathione (GSH) ester (10^–4 mol/L) prevented tolerance and the effects of GTN on mitochondrial respiration and ALDH-2 activity. Biotransformation of GTN requires functionally active mitochondria and induces reactive oxygen species production and oxidative stress within this organelle, as it is inhibited by mitochondrial-targeted antioxidants and is absent in HUVEC⁰ cells. Experiments analyzing complex I–dependent respiration demonstrate that its inhibition by GTN is prevented by mitochondrial-targeted antioxidants. Furthermore, in presence of succinate (10x10^–3 mol/L), a complex II electron donor added to bypass complex I–dependent respiration, GTN-treated cells exhibited O₂ consumption rates similar to those of controls, thus suggesting that complex I was affected by GTN. We propose that, following prolonged treatment with GTN in addition to ALDH-2, complex I is a target for mitochondrially generated reactive oxygen species. Our data also suggest a role for mitochondrial-targeted antioxidants as therapeutic tools in the control of the tolerance that accompanies chronic nitrate use.

Key Words: nitroglycerin • endothelium • oxidative stress • mitochondria • antioxidant

This article has been cited by other articles:

				V. M. Victor, M. Rocha, C. Banuls, M. Sanchez-Serrano, E. Sola, M. Gomez, and A. Hernandez-Mijares Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3505 - 3512. [Abstract] [Full Text] [PDF]

				D. Graham, N. N. Huynh, C. A. Hamilton, E. Beattie, R. A.J. Smith, H. M. Cocheme, M. P. Murphy, and A. F. Dominiczak Mitochondria-Targeted Antioxidant MitoQ10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy Hypertension, August 1, 2009; 54(2): 322 - 328. [Abstract] [Full Text] [PDF]

				M. V. Wenzl, M. Beretta, A. C. F. Gorren, A. Zeller, P. K. Baral, K. Gruber, M. Russwurm, D. Koesling, K. Schmidt, and B. Mayer Role of the General Base Glu-268 in Nitroglycerin Bioactivation and Superoxide Formation by Aldehyde Dehydrogenase-2 J. Biol. Chem., July 24, 2009; 284(30): 19878 - 19886. [Abstract] [Full Text] [PDF]

				A. Pautz, P. Rauschkolb, N. Schmidt, J. Art, M. Oelze, P. Wenzel, U. Forstermann, A. Daiber, and H. Kleinert Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects Physiol Genomics, July 9, 2009; 38(2): 176 - 185. [Abstract] [Full Text] [PDF]

				P. Wenzel, E. Schulz, T. Gori, M. A. Ostad, F. Mathner, S. Schildknecht, S. Gobel, M. Oelze, D. Stalleicken, A. Warnholtz, et al. Monitoring White Blood Cell Mitochondrial Aldehyde Dehydrogenase Activity: Implications for Nitrate Therapy in Humans J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 63 - 71. [Abstract] [Full Text] [PDF]

				V. M. Victor, C. Nunez, P. D'Ocon, C. T. Taylor, J. V. Esplugues, and S. Moncada Regulation of Oxygen Distribution in Tissues by Endothelial Nitric Oxide Circ. Res., May 22, 2009; 104(10): 1178 - 1183. [Abstract] [Full Text] [PDF]

				J. S. Stamler Nitroglycerin-Mediated S-Nitrosylation of Proteins: A Field Comes Full Cycle Circ. Res., September 12, 2008; 103(6): 557 - 559. [Full Text] [PDF]

				R. Guo, X.-P. Chen, X. Guo, L. Chen, D. Li, J. Peng, and Y.-J. Li Evidence for Involvement of Calcitonin Gene-Related Peptide in Nitroglycerin Response and Association With Mitochondrial Aldehyde Dehydrogenase-2 (ALDH2) Glu504Lys Polymorphism J. Am. Coll. Cardiol., September 9, 2008; 52(11): 953 - 960. [Abstract] [Full Text] [PDF]

				A. Daiber and T. Gori Vascular tolerance to nitroglycerin in ascorbate deficiency: results are in favour of an important role of oxidative stress in nitrate tolerance Cardiovasc Res, September 1, 2008; 79(4): 722 - 723. [Full Text] [PDF]

				U. Hink, A. Daiber, N. Kayhan, J. Trischler, C. Kraatz, M. Oelze, H. Mollnau, P. Wenzel, C. F. Vahl, K. K. Ho, et al. Oxidative Inhibition of the Mitochondrial Aldehyde Dehydrogenase Promotes Nitroglycerin Tolerance in Human Blood Vessels J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2226 - 2232. [Abstract] [Full Text] [PDF]

				D. D. Gutterman Combating Nitrate Tolerance: A Novel Endogenous Mechanism Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1673 - 1676. [Full Text] [PDF]

				P. Wenzel, M. Oelze, M. Coldewey, M. Hortmann, A. Seeling, U. Hink, H. Mollnau, D. Stalleicken, H. Weiner, J. Lehmann, et al. Heme Oxygenase-1: A Novel Key Player in the Development of Tolerance in Response to Organic Nitrates Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1729 - 1735. [Abstract] [Full Text] [PDF]